Wegovy is an effective treatment for weight loss, and studies show that the 2.4mg maintenance dose works for 83.5% of people who take it
Future animal trials are needed to fully elucidate any potential BPC-157 cancer risk and its potential effect on cancer progression
BPC-157 is stranger and narrower than that: one Croatian lab, a disputed origin, no convincing human trial, and a vessel-repair pitch that lands very differently when the vessel in question is your own aorta
(However, note that when injecting intramuscularly or subcutaneously, any trace preservative is generally well tolerated
10.1016/j.smrv.2022.101692 7 ChoudhuryM
Key Benefits (Research Purposes Only) Enhanced tissue and injury recovery Supports joint, tendon, and ligament healing Synergistic anti-inflammatory effects Promotes angiogenesis and cellular repair